About Index Trending news
Lists
Pricing
Cleveland BioLabs

Cleveland BioLabs

Cleveland BioLabs

Clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection.

Elsewhere

Alexa global traffic share

04 Feb 2015
$4,200,000
Post-IPO equity
03 Jul 2014
$3,500,000
Venture capital